1. Anasetti C, Martin PJ, Morishita Y, Ledbetter JA, Hansen JA (1987) Enhancement of cytolytic activity by bridging the CD2 sheep erythrocyte binding protein and the CD16 Fc-receptor. In: McMichael AJ (ed) Leukocyte typing III. Oxford University Press, Oxford, pp 131–133
2. Anderson JE, Appelbaum FR, Schoch G, Gooley T, Anasetti C, Bensinger Wl, Bryant E, Buckner CD, Chauncey TR, Clift RA, Doney K, Flowers M, Hansen JA, Martin PJ, Matthews DC, Sanders JE, Shulman H, Sullivan KM, Witherspoon RP, Storb R (1996) Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors. Blood 87:51–58
3. Ascensao J, Pahwa R, Kagan W, Hansen J, Moore M, Good R (1976) Aplastic anaemia: evidence for an immunological mechanism. Lancet 1:669–671
4. Bader-Meunier B, Mielot F, Tchemia G, Buisine J, Delsol G, Duchayne E, Lemerle S, Leverger G, de Lumley L, Manel AM (1996) Myelodysplastic syndromes in childhood: report of 49 patients from a French multicentre study. Br J Haematol 92:344–350
5. Badger CC, Bernstein ID (1983) Prospects for antibody therapy of leukemia: experimental studies in murine leukemia. In: Langman RE, Trowbridge IS, Dulbecco R (eds) Monoclonal antibodies and cancer, proceedings of the 4th Armand Hammer Cancer Symposium. Academic Press, pp 63–72